The global Clinical Trial Patient Recruitment Services Market size is expected to reach USD 1.56 billion by 2030 witnessing a CAGR of 8.07% from 2023 to 2030, according to a new report by Grand View Research, Inc.
The growing pharmaceutical and medical sectors, increasing demand for clinical studies, and adoption of decentralized clinical trials are a few of the factors supporting the growth of the clinical trial patient recruitment services market.
However, the COVID-19 pandemic has affected the global market, the outbreak of COVID-19 has caused a voluntary pause in the clinical trials across the globe. The temporary lockdown has significantly disrupted clinical trials, especially in the patient recruitment industry. The lockdown has restricted the patient’s visits to trial sites, which has ultimately led to significant dropouts of the patient population from several clinical trials.
However, companies operating across the industry have focused on mitigating the negative impact of the pandemic by adopting measures such as mergers and acquisitions, implementation of digital technologies such as decentralized clinical trials, remote monitoring of patients, and a few others. Such factors helped the industry to flourish back to its normal growth rate post-2021.
Pharmaceutical organizations are progressively focusing on R&D activities to remain competitive & flexible in the world of healthcare expertise. Companies are focusing on outsourcing tasks ranging from basic research to patient enrollment services. Digital methods of communication are one of the most recent trends witnessed across the patient recruitment services market.
With the help of online platforms, the recruitment growth seems to be streamlining. The majority of people learn about clinical trials through online sources compared to traditional print or TV/radio outreach. Hence, several e-recruitment tactics are evolving, such as social media, web listening, as well as online screeners.
In addition, with the increasing usage of mobile devices, the use of smartphone applications and text messaging has become more widespread. For instance, in North America, about 11% of clinical studies involve social media communications. Hence, the aforementioned factors are anticipated to support the growth of the market.
Related Press Release@ Clinical Trial Patient Recruitment Services Market Report
Clinical Trial Patient Recruitment Services Market Report Highlights
- The phase III segment dominated the market with a revenue share of more than 57.2% in 2022 due to the high cost associated with phase III studies
- The patient recruitment & registry services segment is anticipated to witness lucrative growth of 8.3% during the forecast period owing to the increasing adoption of digital technologies in patient enrolment services
- Pain and Anesthesia in terms of therapeutic areas held the highest market share of 13.7% in 2021. This is because the cost related to pain management is significantly higher than in other therapeutic areas, thus simultaneously increasing the fees for patient recruitment and retention services
- In terms of age group, the adult (18 - 64 Years) segment is expected to witness a considerable growth rate across the forecast timeframe, owing to the increasing prevalence of health conditions in the age group
- North America held the largest share of 50.1% in 2022. The market is expected to grow significantly, driven by the region's substantial number of ongoing clinical trials.
Request For A Free Consultation@ https://www.grandviewresearch.com/request-free-consultation/452635/rfc
Clinical Trial Patient Recruitment Services Market Segmentation
Grand View Research has segmented the global clinical trial patient recruitment services market based on service type, therapeutic area, age group, phase, and region:
Clinical Trial Patient Recruitment Services Service Type Outlook (Revenue, USD Million, 2018 - 2030)
- Patient Recruitment & Registry Services
- Patient Retention Services
- Others
Clinical Trial Patient Recruitment Services Phase Outlook (Revenue, USD Million, 2018 - 2030)
- Phase I
- Phase II
- Phase III
- Phase IV
Clinical Trial Patient Recruitment Services Therapeutic Areas Outlook (Revenue, USD Million, 2018 - 2030)
- Respiratory Diseases
- Pain and Anesthesia
- Oncology
- Central Nervous System
- Cardiovascular
- Endocrine
- Anti-Infective
- Others
Clinical Trial Patient Recruitment Services Age Group Outlook (Revenue, USD Million, 2018 - 2030)
- Child (Birth-17 Years)
- Adult (18 - 64 Years)
- Older Adults (65 Years+)
Clinical Trial Patient Recruitment Services Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
